GAP180: A Potential Drug Target Or Biomarker (G83956)

Target Name: RACGAP1P1

NCBI ID: G83956

RACGAP1P1

Other Name(s): FKSG42 | RACGAP1P | Rac GTPase activating protein 1 pseudogene 1

GAP180: A Potential Drug Target Or Biomarker

RACGAP1P1 (FKSG42) is a gene that encodes a protein known as GAP180, which is a key regulator of the cytoskeleton and cell-cell adhesion. The cytoskeleton is a complex network of filaments and organizing structures that provide structural support to cells, while cell-cell adhesion ensures the integrity of cell-cell interactions. GAP180 plays a crucial role in the regulation of these processes, and is therefore a potential drug target or biomarker.

The discovery of GAP180 and its function in the regulation of cytoskeleton and cell-cell adhesion has been the subject of extensive research in recent years. GAP180 is highly conserved across various species, and its function has been verified in numerous in vitro and in vivo studies. One of the most significant findings is that GAP180 plays a critical role in the regulation of cell-cell adhesion, as it is involved in the formation of tight junctions, which are a type of cell-cell adhesion structure.

In addition to its role in cell-cell adhesion, GAP180 has also been shown to play a role in the regulation of cytoskeleton dynamics. GAP180 has been shown to play a role in the regulation of microtubule dynamics, as well as the stability of the cytoskeleton. These findings suggest that GAP180 may be a useful drug target or biomarker for the treatment of various diseases associated with disrupted cytoskeleton and cell-cell adhesion, such as cancer, neurodegenerative diseases, and autoimmune disorders.

The targeting of GAP180 as a drug or biomarker also has the potential to provide new insights into the underlying mechanisms of these diseases. For example, the regulation of GAP180 by various chemical modulators, such as drugs or small molecules, may provide new avenues for the development of therapeutic strategies for these diseases. Additionally, the study of GAP180's downstream targets, such as its interactions with other proteins, may provide new insights into the complex mechanisms of its function in the regulation of cytoskeleton and cell-cell adhesion.

Conclusion

In conclusion, RACGAP1P1 (FKSG42) is a gene that encodes a protein with significant potential as a drug target or biomarker. Its function in the regulation of cytoskeleton and cell-cell adhesion makes it an attractive target for the development of new therapeutic strategies for various diseases associated with these processes. Further research is needed to fully understand the mechanisms of GAP180's function in these processes, as well as its potential as a drug or biomarker.

Protein Name: Rac GTPase Activating Protein 1 Pseudogene 1

The "RACGAP1P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RACGAP1P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets